Vaccines against transmissible spongiform encephalopathies: An urgent need?

Human Vaccines

Volumn 4, Issue 1, 2008, Pages 79-81

  Bade, Steffen ^a   Frey, Andreas ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Immunization; Prion diseases; Prions; Transmissible spongiform encephalopathies; TSE; Vaccines; Variant Creutzfeldt Jakob disease; Zoonoses

Indexed keywords

PRION PROTEIN ANTIBODY; VACCINE;

BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; HUMAN; INFECTION PREVENTION; NOTE; PASSIVE IMMUNIZATION; PRION DISEASE; VACCINATION;

EID: 44649190412     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.4.1.4824     Document Type: Note

References (13)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44.
2. Mabbott NA, MacPherson GG. Prions and their lethal journey to the brain. Nat Rev Microbiol 2006; 4:201-11.
3. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-5.
4. http://www.who.int/mediacentre/factsheets/fs237/en/
5. Scherbel C, Pichner R, Groschup MH, Mueller-Hellwig S, Scherer S, Dietrich R, Maertlbauer E, Gareis M. Infectivity of scrapie prion protein (Prp(sc)) following in vitro digestion with bovine gastrointestinal microbiota. Zoonoses Public Health 2007; 54:185-90.
6. Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, Beekes M, Terytze K. Scrapie agent (strain 263K) can transmit disease via the oral route after persistence in soil over years. PLoS ONE 2007; 2:e435.
7. Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM. Oral transmissibility of prion disease is enhanced by binding to soil particles. PLoS Pathog 2007; 3:e93.
8. Miller MW, Williams ES, Hobbs NT, Wolfe LL. Environmental sources of prion transmission in mule deer. Emerg Infect Dis 2004; 10:1003-6.
9. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, Alpers MP. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 2006; 367:2068-74.
10. Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303:1514-6.
11. Goni F, Knudsen E, Schreiber F, Scholtzova H, Pankiewicz J, Carp R, Meeker HC, Rubenstein R, Brown DR, Sy MS, Chabalgoity JA, Sigurdsson EM, Wisniewski T. Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 2005; 133:413-21.
12. Bade S, Baier M, Boetel T, Frey A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 2006; 24:1242-53.
13. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003; 422:80-3.